Should You Buy Bristol Myers Squibb Stock Right Now for the Yield Alone?
Key PointsPatent cliff concerns continue to weigh down Bristol Myers Squibb's stock.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.